US 7427639
β2-adrenergic receptor agonists
granted A61KA61K31/137A61K31/167
Quick answer
US patent 7427639 (β2-adrenergic receptor agonists) held by Theravance, Inc. expires Mon Sep 18 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Theravance, Inc.
- Grant date
- Tue Sep 23 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 18 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 4
- CPC classes
- A61K, A61K31/137, A61K31/167, A61K31/403, A61K31/404